Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Robina M, Meyer"'
Autor:
Lukas Berger, Robina M. Meyer, Sebastian Nehring, Joerg Nerkamp, Wolfgang Friess, Stefan Scheler
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics. 160:134-142
Monoclonal antibodies (mAbs) are valuable tools both in therapy and in diagnostic. Their tendency to aggregate is a serious concern. Since a mAb drug substance (DS) is composed of different variants, it is important for manufacturers to know the beha
Autor:
Robina M, Meyer, Sofya, Aleshkevich, Lukas, Berger, Joerg, Nerkamp, Stefan, Scheler, Wolfgang, Friess
Publikováno v:
International Journal of Pharmaceutics. 621:121760
Biopharmaceutical products are subject to in depth analysis to ensure and improve their safety and efficacy. As part of this effort the stability and aggregation mechanisms of the therapeutic protein is characterized over the whole life cycle. The st
Autor:
Lukas Berger, Wolfgang Friess, Stefan Scheler, Robina M. Meyer, Sebastian Nehring, Joerg Nerkamp
Publikováno v:
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V. 158
Biopharmaceutical products contain conformational and chemical variants, that are typically well characterized regarding identity and activity. However, little is known about their self-interaction propensity and tendency to unfold, which are critica